MedPath

MAR-ABIRATERONE

MAR-ABIRATERONE

Approved
DIN Number

02503999

Drug Class

Human

Market Date

Feb 3, 2021

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02503999
AIG Number0152948002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BX03 ABIRATERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ABIRATERONE ACETATEActive
Strength: 500 MG
Monograph: ABIRATERONE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.